Full-Time

Senior Manager, Global Quality Systems

Posted on 8/20/2026

CooperSurgical

CooperSurgical

1,001-5,000 employees

Provides reproductive health products and services

No salary listed

Trumbull, CT, USA + 1 more

More locations: Livingston, NJ, USA

In Person

The position may require 20% domestic or international travel.

Bachelor's

Category
Medical, Clinical & Veterinary (1)
Required Skills
Veeva
Data Visualization
Data Analysis
Excel/Numbers/Sheets

Get referred to CooperSurgical

See people who can refer or advise you

Requirements
  • Strong working knowledge of MasterControl, Veeva, Trackwise, or similar electronic Quality Management System platforms.
  • Solid understanding of 21 CFR 820, ISO 13485, EU MDR, and MDSAP.
  • Demonstrated ability to manage and develop teams.
  • Ability to balance operational priorities with compliance requirements.
  • Strong organizational, analytical, and communication skills.
  • Ability to collaborate across global, cross-functional groups.
  • At least 8 years of experience in quality management systems within a regulated medical technology industry.
  • At least 7 years of people leadership and team development experience.
  • Experience managing quality systems with ISO 13485, FDA 21 CFR Part 820, MDSAP, and EU MDR requirements.
  • A bachelor's degree in a relevant field such as Engineering, Life Sciences, Quality, or a related discipline.
Responsibilities
  • Support the governance, effectiveness, and continuous improvement of the global Quality Management System.
  • Drive harmonization, compliance, and operational excellence across global quality system processes.
  • Partner with process owners and cross-functional stakeholders to identify and mitigate quality system risks while ensuring inspection readiness.
  • Lead the global Management Review program, including planning, reporting, action tracking, and continuous improvement.
  • Develop and maintain quality system key performance indicators, dashboards, and performance reporting.
  • Prepare executive-level reporting on Quality Management System health, quality objectives, risks, and improvement opportunities.
  • Monitor process effectiveness and drive improvements that enhance compliance, efficiency, and user experience.
  • Monitor evolving global regulations, standards, guidance documents, and industry best practices impacting the Quality Management System.
  • Lead quality system impact assessments and gap analyses to determine the effect of regulatory and standards changes on existing processes.
  • Develop and track implementation plans for incorporating regulatory and standards requirements into the Quality Management System.
  • Partner with Regulatory Affairs and Quality leadership to evaluate new or revised regulatory requirements.
  • Lead Quality Systems due diligence, integration planning, and Quality Management System harmonization activities associated with acquisitions and strategic business initiatives.
  • Assess quality system maturity, identify compliance gaps, and implement integration plans for acquired entities.
  • Support implementation and optimization of electronic Quality Management Systems and related quality system enhancement initiatives.
  • Support regulatory inspections, audits, and remediation activities as required.
  • Lead, coach, and develop a team responsible for Quality Systems governance, reporting, compliance monitoring, and improvement initiatives.
  • Establish performance expectations, prioritize resources, and foster a culture of quality, accountability, and continuous improvement.
Desired Qualifications
  • Experience participating in or supporting large-scale enterprise software implementations, including data migration and data mapping activities.
  • Advanced proficiency in Excel for data analysis and reporting.
  • Professional certification such as Certified Quality Auditor or similar.
  • Exposure to adjacent quality system compliance requirements such as 21 CFR Part 210/211.
  • Prior involvement in supporting external and internal audits.
  • Experience with electronic Quality Management Systems and/or implementation of systems such as Veeva, Trackwise, or MasterControl.
  • Professional ASQ certification such as CQPA, CQA, or CMQ/OE.
  • Project Management Professional certification.

What CooperSurgical does: CooperSurgical develops and provides products, technologies, and services that support women’s, babies’, and families’ health around the world. How its products work: The company offers a range of reproductive health solutions, including contraception, fertility support, and preventive and therapeutic gynecological care. These products assist clinicians and patients through devices, tests, and therapies designed to aid choice and care in reproductive health. How it differs from competitors: CooperSurgical focuses on a broad set of reproductive health needs—covering contraception, fertility, and gynecologic care—trusted by clinicians worldwide for a wide range of tools and services, which can enable more integrated care compared to providers focused on a narrower segment. Goal: To empower individuals and healthcare professionals to make informed health and life choices and improve care for women, babies, and families globally.

Company Size

1,001-5,000

Company Stage

N/A

Total Funding

N/A

Headquarters

Trumbull, Connecticut

Founded

1990

Get referred to CooperSurgical

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Paragard's 2024 single-hand inserter improved usability and expanded commercial appeal.
  • The ZyMōt and obp Surgical acquisitions broadened reproductive and surgical offerings.
  • June 2026 sale talks drew multiple bidders, validating CooperSurgical's asset value.

What critics are saying

  • A March 2026 embryo-loss class action attacks trust in CooperSurgical IVF media.
  • Management's 2026 divestiture process signals CooperSurgical can become a sale asset, not a standalone strategy.
  • If IVF customers defect after the recall, CooperSurgical's fertility franchise loses its core growth engine.

What makes CooperSurgical unique

  • CooperSurgical owns Paragard, a rare long-duration nonhormonal contraceptive franchise.
  • Its fertility portfolio spans IVF media, sperm separation, and labor-and-delivery devices.
  • The 2025 Europe direct-sales shift strengthens clinician relationships in France, Italy, Germany, and Spain.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

401(k) Retirement Plan

Parental Leave

Fertility Treatment Support

Paid Vacation

Paid Sick Leave

Paid Holidays

Hybrid Work Options

Company News

CooperSurgical
Feb 12th, 2026
CooperSurgical to Launch Direct Sales Model for Labor and Delivery Portfolio in Key European Markets

CooperSurgical to launch direct sales model for Labor and Delivery portfolio in key european markets. TRUMBULL, CT, December 11, 2025, CooperSurgical(R), a leader in women's healthcare and fertility solutions, today announced a strategic shift to a direct sales model for its premier Labor and Delivery products in France, Italy, Germany, and Spain. This transition will forge a closer relationship with healthcare providers, reinforcing the company's commitment to advancing the standard of care for women and babies. Beginning in the company's fiscal first quarter, healthcare providers and healthcare facilities in these markets will gain the ability to procure products directly from CooperSurgical. The portfolio includes the vacuum-assisted delivery products, Fetal Pillow(TM) cephalic elevation device, the INSORB(R) subcuticular skin stapler, and the Lone Star(R) retractor system. This change from a distributor-led model is designed to streamline the customer's ordering process, facilitate easier access to these critical technologies, and provide direct support from CooperSurgical's dedicated customer care center. By creating a direct channel, CooperSurgical aims to better support the clinical community, ensuring that physicians have the resources and guidance needed to implement these innovative solutions effectively. This initiative is central to the company's mission of delivering technologies that support healthier families. About CooperSurgical CooperSurgical is a leading company dedicated to advancing the health of women, babies, and families. The company's portfolio offers effective solutions that support clinical efficiency from conception to delivery. With a history of innovation in the fertility and women's health field, CooperSurgical has pioneered new technologies and continues to drive progress in the industry. Existing Customers - Order directly from CooperSurgical Previously purchased through a distributor? CooperSurgical, Inc. has simplified the process. Its dedicated sales team can assist with product availability, pricing, ordering, and delivery information specific to your country

PR Newswire
Mar 10th, 2025
2025 Inception Fertility Physician Summit Brings Together Thought Leaders, Researchers, And Clinicians From Across The Company To Celebrate Patient Dedication, Collaborate On Research, And Discuss The Future Of Fertility Care

North America's largest provider of fertility services collaborates, celebrates achievements in fertility care including unparalleled patient services. HOUSTON, March 10, 2025 /PRNewswire/ -- Inception Fertility™ (Inception), North America's largest provider of comprehensive fertility services, held its Annual Inception Physician Summit in Nashville, Tennessee, February 22-25, 2024. The Summit brings together team members, including reproductive specialists and clinical managers, from across Inception's vast network of global fertility clinics, The Prelude Network®, to share best practices and resources that make each clinic a leading fertility provider in their respective markets

FinSMEs
Jan 15th, 2025
Granata Bio Secures $15M Series A+ Funding

Granata Bio Corporation, a biopharma company in Boston, MA, raised $15 million in Series A+ funding. Investors included Gedeon Richter, CooperSurgical, and Amboy Street Ventures. The funds will support the company's pipeline and exploration of new assets in reproductive health. Granata Bio has raised over $30 million to date.

Daily Journal Corporation
Oct 9th, 2024
Toxic embryo culture lawsuits allowed to proceed

Four plaintiffs have filed separate lawsuits against CooperSurgical Inc., accusing the company of selling defective embryo culture which caused embryos to die.

Medical Device Network
Sep 4th, 2024
CooperSurgical introduces single-hand inserter for Paragard IUD

CooperSurgical has introduced a new single-hand inserter for the Paragard copper intrauterine device (IUD).